A high cerebrospinal fluid soluble TREM2 level is associated with slow clinical progression of Alzheimer's disease

INTRODUCTION: The progression rate of Alzheimer's disease (AD) varies and might be affected by the triggering receptor expressed on myeloid cells (TREM2) activity. We explored if cerebrospinal fluid (CSF) soluble TREM2 (sTREM2), a proxy of microglial activity, is associated with clinical progre...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Alzheimers Dement (Amst)
Main Authors: Edwin, Trine Holt, Henjum, Kristi, Nilsson, Lars N.G., Watne, Leiv Otto, Persson, Karin, Eldholm, Rannveig Sakshaug, Saltvedt, Ingvild, Halaas, Nathalie Bodd, Selbæk, Geir, Engedal, Knut, Strand, Bjørn Heine, Knapskog, Anne‐Brita
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2020
Assuntos:
Cerebrospinal Fluid Biomarkers
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7720866/
https://ncbi.nlm.nih.gov/pubmed/33313376
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/dad2.12128
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados